Aquestive secures $75 million funding from RTW for Anaphylm launch

Go back to Aquestive secures $75 million funding from RTW for Anaphylm launch
(NASDAQ: AQST) Delayed: 5.02 --0 (-0%)
Previous Close $5.02    52 Week High
Open $5.02    52 Week Low
Day High $5.02    P/E N/A 
Day Low $5.02    EPS
Volume 25